| pubmed-article:21429799 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:21429799 | lifeskim:mentions | umls-concept:C0278488 | lld:lifeskim |
| pubmed-article:21429799 | lifeskim:mentions | umls-concept:C0796392 | lld:lifeskim |
| pubmed-article:21429799 | lifeskim:mentions | umls-concept:C0144576 | lld:lifeskim |
| pubmed-article:21429799 | lifeskim:mentions | umls-concept:C0034897 | lld:lifeskim |
| pubmed-article:21429799 | lifeskim:mentions | umls-concept:C1517927 | lld:lifeskim |
| pubmed-article:21429799 | lifeskim:mentions | umls-concept:C0205390 | lld:lifeskim |
| pubmed-article:21429799 | lifeskim:mentions | umls-concept:C0599724 | lld:lifeskim |
| pubmed-article:21429799 | lifeskim:mentions | umls-concept:C1708063 | lld:lifeskim |
| pubmed-article:21429799 | lifeskim:mentions | umls-concept:C0205195 | lld:lifeskim |
| pubmed-article:21429799 | lifeskim:mentions | umls-concept:C2347295 | lld:lifeskim |
| pubmed-article:21429799 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:21429799 | pubmed:dateCreated | 2011-4-5 | lld:pubmed |
| pubmed-article:21429799 | pubmed:databankReference | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21429799 | pubmed:abstractText | Vascular endothelial growth factor (VEGF) has a crucial role in angiogenesis, and is a valid target in metastatic breast cancer. Motesanib is an investigational oral inhibitor of VEGF receptors. We aimed to determine whether treatment with motesanib plus paclitaxel is better than placebo plus paclitaxel in patients with HER2-negative locally recurrent or metastatic breast cancer. | lld:pubmed |
| pubmed-article:21429799 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21429799 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21429799 | pubmed:language | eng | lld:pubmed |
| pubmed-article:21429799 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21429799 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:21429799 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21429799 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21429799 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21429799 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21429799 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21429799 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21429799 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21429799 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21429799 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21429799 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:21429799 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:21429799 | pubmed:issn | 1474-5488 | lld:pubmed |
| pubmed-article:21429799 | pubmed:author | pubmed-author:MackeyJohn... | lld:pubmed |
| pubmed-article:21429799 | pubmed:author | pubmed-author:CrownJohnJ | lld:pubmed |
| pubmed-article:21429799 | pubmed:author | pubmed-author:MartinMiguelM | lld:pubmed |
| pubmed-article:21429799 | pubmed:author | pubmed-author:RamosManuelM | lld:pubmed |
| pubmed-article:21429799 | pubmed:author | pubmed-author:LindsayMary-A... | lld:pubmed |
| pubmed-article:21429799 | pubmed:author | pubmed-author:EiermannWolfg... | lld:pubmed |
| pubmed-article:21429799 | pubmed:author | pubmed-author:KennedyM... | lld:pubmed |
| pubmed-article:21429799 | pubmed:author | pubmed-author:MorooseRebecc... | lld:pubmed |
| pubmed-article:21429799 | pubmed:author | pubmed-author:HeiYong-Jiang... | lld:pubmed |
| pubmed-article:21429799 | pubmed:author | pubmed-author:RocheHenriH | lld:pubmed |
| pubmed-article:21429799 | pubmed:author | pubmed-author:BañosAnaA | lld:pubmed |
| pubmed-article:21429799 | pubmed:author | pubmed-author:AlbaEmilioE | lld:pubmed |
| pubmed-article:21429799 | pubmed:author | pubmed-author:PinterTamasT | lld:pubmed |
| pubmed-article:21429799 | pubmed:author | pubmed-author:PriouFrankF | lld:pubmed |
| pubmed-article:21429799 | pubmed:author | pubmed-author:LatreilleJean... | lld:pubmed |
| pubmed-article:21429799 | pubmed:author | pubmed-author:ProvencherLou... | lld:pubmed |
| pubmed-article:21429799 | pubmed:author | pubmed-author:PienkowskiTad... | lld:pubmed |
| pubmed-article:21429799 | pubmed:author | pubmed-author:AdroverEncarn... | lld:pubmed |
| pubmed-article:21429799 | pubmed:author | pubmed-author:SnyderRaymond... | lld:pubmed |
| pubmed-article:21429799 | pubmed:author | pubmed-author:RupinMatthieu... | lld:pubmed |
| pubmed-article:21429799 | pubmed:author | pubmed-author:LangIstvanI | lld:pubmed |
| pubmed-article:21429799 | pubmed:author | pubmed-author:AlmelSachinS | lld:pubmed |
| pubmed-article:21429799 | pubmed:author | pubmed-author:RolskiJanuszJ | lld:pubmed |
| pubmed-article:21429799 | pubmed:author | pubmed-author:HurvitzSaraS | lld:pubmed |
| pubmed-article:21429799 | pubmed:author | pubmed-author:Jagie??o-Grus... | lld:pubmed |
| pubmed-article:21429799 | pubmed:author | pubmed-author:MunozMontserr... | lld:pubmed |
| pubmed-article:21429799 | pubmed:author | pubmed-author:AdewoyeHenryH | lld:pubmed |
| pubmed-article:21429799 | pubmed:author | pubmed-author:CabaribereDav... | lld:pubmed |
| pubmed-article:21429799 | pubmed:author | pubmed-author:LemmerickYasm... | lld:pubmed |
| pubmed-article:21429799 | pubmed:author | pubmed-author:TRIO 010... | lld:pubmed |
| pubmed-article:21429799 | pubmed:copyrightInfo | Copyright © 2011 Elsevier Ltd. All rights reserved. | lld:pubmed |
| pubmed-article:21429799 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:21429799 | pubmed:volume | 12 | lld:pubmed |
| pubmed-article:21429799 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:21429799 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:21429799 | pubmed:pagination | 369-76 | lld:pubmed |
| pubmed-article:21429799 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:21429799 | pubmed:meshHeading | pubmed-meshheading:21429799... | lld:pubmed |
| pubmed-article:21429799 | pubmed:meshHeading | pubmed-meshheading:21429799... | lld:pubmed |
| pubmed-article:21429799 | pubmed:meshHeading | pubmed-meshheading:21429799... | lld:pubmed |
| pubmed-article:21429799 | pubmed:meshHeading | pubmed-meshheading:21429799... | lld:pubmed |
| pubmed-article:21429799 | pubmed:meshHeading | pubmed-meshheading:21429799... | lld:pubmed |
| pubmed-article:21429799 | pubmed:meshHeading | pubmed-meshheading:21429799... | lld:pubmed |
| pubmed-article:21429799 | pubmed:meshHeading | pubmed-meshheading:21429799... | lld:pubmed |
| pubmed-article:21429799 | pubmed:meshHeading | pubmed-meshheading:21429799... | lld:pubmed |
| pubmed-article:21429799 | pubmed:meshHeading | pubmed-meshheading:21429799... | lld:pubmed |
| pubmed-article:21429799 | pubmed:meshHeading | pubmed-meshheading:21429799... | lld:pubmed |
| pubmed-article:21429799 | pubmed:meshHeading | pubmed-meshheading:21429799... | lld:pubmed |
| pubmed-article:21429799 | pubmed:meshHeading | pubmed-meshheading:21429799... | lld:pubmed |
| pubmed-article:21429799 | pubmed:meshHeading | pubmed-meshheading:21429799... | lld:pubmed |
| pubmed-article:21429799 | pubmed:meshHeading | pubmed-meshheading:21429799... | lld:pubmed |
| pubmed-article:21429799 | pubmed:meshHeading | pubmed-meshheading:21429799... | lld:pubmed |
| pubmed-article:21429799 | pubmed:meshHeading | pubmed-meshheading:21429799... | lld:pubmed |
| pubmed-article:21429799 | pubmed:year | 2011 | lld:pubmed |
| pubmed-article:21429799 | pubmed:articleTitle | Motesanib, or open-label bevacizumab, in combination with paclitaxel, as first-line treatment for HER2-negative locally recurrent or metastatic breast cancer: a phase 2, randomised, double-blind, placebo-controlled study. | lld:pubmed |
| pubmed-article:21429799 | pubmed:affiliation | Grupo Español de Investigación en Cáncer de Mama, Madrid, Spain. mmartin@geicam.org | lld:pubmed |
| pubmed-article:21429799 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:21429799 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:21429799 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:21429799 | pubmed:publicationType | Clinical Trial, Phase II | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:21429799 | lld:pubmed |
